Pay in 4 interest-free payments of $5.73 Learn more
Ships within 48 hours · Estimated delivery Aug 24 - Aug 29
Clinical trials have focused on people living with obesity, early research shows it could, if licensed, be used for conditions like type 2 diabetes and fatty liver disease
Some patients taking oral formulations report slightly increased upper gastrointestinal symptoms including heartburn or stomach discomfort compared to injectable forms, potentially related to local gastric effects before absorption
Biddle A, Stewart L, Blanchard J, Leschine S (2013) Untangling the genetic basis of fibrolytic specialization by Lachnospiraceae and Ruminococcaceae in diverse gut communities
Insider Tip: This product was previously known as Buffet + Copper Peptides 1%, but it was recently renamed
%20(1).png)
